Clinical Trial: EMVITAL + EMFACE Combination Therapy for Temporomandibular Joint (TMJ) Pain Relief

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661121) titled 'EMVITAL + EMFACE Combination Therapy for Temporomandibular Joint (TMJ) Pain Relief' on June 16.

Brief Summary: This prospective, multi-center, open-label, single-arm clinical study will evaluate the efficacy and performance of the BTL-043 and BTL-785F devices for alleviating TMJ pain. Up to 60 subjects will undergo four treatment visits, administered 2-10 days apart, followed by 1-month and 3-month follow-up visits. During a single treatment session at each visit, subjects will receive consecutive treatment with both devices. At baseline, informed consent, eligibility assessment, Fitzpatrick phototype evaluation, TMD Disability Inde...